I wish I had known more about alcohol when I started drinking
You're going to want to sit down with a big glass of water for this one, because I'm afraid I have some bad news. Here we go: alcohol is not terribly good for you. Shocker, right? You've probably never heard anything like this before in your life. No doubt, you've been choking down a glass of pinot with dinner whenever you can stomach it because you thought it was good for your cholesterol. Instead, it is elevating your risk of cancer.
If public health experts have their way, the fact that alcohol is carcinogenic is going to be very hard for British drinkers to ignore. Dozens of medical and health organisations recently wrote to Keir Starmer urging the prime minister to force companies to include 'bold and unambiguous' labels on booze bottles, warning that alcohol causes cancer.
Currently only about a quarter of countries require any sort of health warnings on alcohol and these are generally vague and in small print. However, there are growing calls for more aggressive messaging. In 2016, South Korea mandated a number of warning labels for alcohol, including one that specified links to liver cancer. (Manufacturers can choose which label to use, and don't need to use the one linked to cancer.) In 2023, meanwhile, Ireland signed a law (which comes into effect next year) that made it the first country to mandate warning labels specifying a direct link between alcohol and fatal cancers.
The US has been mulling a similar move: Vivek Murthy, the US surgeon general under Joe Biden, called for alcohol warnings in a report published in January. Might Donald Trump's current nominee for surgeon general, Casey Means (a wellness influencer who doesn't have an active medical licence), carry out these recommendations? Possibly. She's been outspoken about the harms of alcohol, albeit in an idiosyncratic way. 'When I'm off my healthy habits, and drinking regularly, it feels like the mystical realm is harder for me to access,' Means wrote in an old blog post about her dry January efforts.
'I so eagerly want to thin that veil between me and the spiritual dimension,' she added, 'so for me, I think alcohol needs to take a lesser role in my life.' Warning: alcohol may give you cancer and also throw your chakras out of balance.
While it may be a little paternalistic, I think putting more explicit warning labels on alcohol is a sensible move. Yes, we all know that alcohol is bad for us, but knowing something in the abstract is very different from being reminded about specific risks at the point of consumption. And while few people labour under the delusion that alcohol is a health product, there is evidence that a lot of people don't understand the risks involved with even relatively small amounts. There are certainly a lot of things I wish I had known about alcohol early on in my drinking life, including the fact that you might not necessarily have any symptoms of liver damage until you are in serious trouble. I am not fully retired from drinking now but, like a lot of people, I'm 'sober curious'.
All that said, I am sceptical about the efficacy of the 'No amount of alcohol is safe for you' messaging put out by the World Health Organization in 2023. Messaging that absolutist can be easy to ignore or can be used to justify binge-drinking. After all, if no amount of alcohol is good for you, then what's the point of stopping at one? Some experts have also argued that the 'Every drop is evil' messaging lacks nuance and cherrypicks data. 'The data do not justify sweeping statements about the effects of moderate alcohol consumption on human health,' two researchers from the Harvard TH Chan School of Public Health said in an opinion piece last year.
In 2018, David Spiegelhalter, a British expert in the public understanding of risk, similarly noted that the public should be given more detail on the degree to which low-level alcohol use actually increases your risk of cancer. He added: 'Claiming there is no 'safe' level [for drinking] does not seem an argument for abstention. There is no safe level of driving, but government do not recommend that people avoid driving. Come to think of it, there is no safe level of living, but nobody would recommend abstention.' He's quite right about that last bit, I'm afraid: recent research shows that life comes with a 100% risk of death. A sobering statistic if ever there was one.
Arwa Mahdawi is a Guardian columnist
Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
19 minutes ago
- Daily Mail
World's most deadly diseases will be kept at new Surrey lab
The world's most dangerous diseases will be researched at state-of-the-art laboratories in Surrey. The brand new National Biosecurity Centre in Weybridge will aim to prevent future pandemics by keeping various incurable and fatal viruses in its facilities. It will be handed the highest classification of lab biosecurity, allowing researchers to study the deadliest diseases, known as biosafety level four pathogens, which include Ebola. This upgrade in rating gives it the same classification as the UK Healthy Security Agency base at Porton Down. But operations in Weybridge will take on a much wider scope, with the facility set to analyse a range of infected farm animals, not just rodents. The facility will also help prepare for the possibility of a terror attack involving biological weapons. Staff at the site will do their research in special self-contained suits with their own air supply, air locks, negative air pressure and disinfection showers, allowing them to safely handle the dangerous viruses. They will also analyse currently unknown diseases including Disease X, a hypothetical pathogen that will lead to the next pandemic. On Monday, the Department for Environment, Food & Rural Affairs announced it would fund the labs with £1billion of taxpayer money, part of a larger £2.8bn revamp of the Government's premier animal disease centre. It comes after warnings from the National Audit Office that the Government was not properly prepared for a major outbreak of animal disease. Such diseases include bird flu, bluetongue and African swine fever and can pose serious threats to England's farming sector, food security, and wildlife, and are a major and increasing risk to public health. About 60 per cent of all known human infectious diseases can be transmitted from animals to people, and three quarters of emerging infectious diseases originate in animals, officials warned. The 'record' investment will complete the redevelopment of the crumbling animal science facilities at Weybridge, which the National Audit Office (NAO) recently warned was at 'very high' risk of site failure. Environment Secretary Steve Reed said: 'The first role of any Government is national security. 'That is why we are making a record investment into the nation's biosecurity capabilities and, in turn, our national security, after years of chronic underfunding. 'Farmers and food producers will now be better protected from diseases, our food security strengthened, and public health better safeguarded against future pandemics.' Jenny Stewart, senior science director at the Animal and Plant Health Agency, which runs the labs, said the funding was a 'vital milestone' in the delivery of the new facilities. 'Our scientists and specialists at Weybridge are at the heart of the UK's disease surveillance and response capability and provide a global centre of expertise,' she added. 'Investment on this scale will enable them to continue their critical work in modern, fit-for-purpose facilities, supported by the very latest technologies.' The Government said work was already under way at the Weybridge site, with the first interim labs to support science ready in 2027 and 2028, and the national biosecurity centre due to be operational in 2033-34.
The Independent
an hour ago
- The Independent
Mother's delight as gene therapy offers hope to three-year-old
A child with a life-threatening disease has become the youngest in the UK to receive a groundbreaking gene therapy. Three-year-old Gunreet Kaur has a rare inherited condition that affects children's physical, mental and behavioural development. Children with aromatic l-amino acid decarboxylase (AADC) deficiency find it difficult to control their head, blood pressure and heart rate. But after receiving the new gene therapy, called Upstaza, Gunreet has made progress that her mother thought would never be possible, such as new movements and vocalising. It is hoped that she will make further strides as she ages. Gunreet, from Hayes in west London, was nine months old when she was diagnosed with the condition. She received the treatment in February 2024 at the world-renowned Great Ormond Street children's hospital (GOSH), which is the only hospital in the UK offering the treatment to children. Sandeep Kaur said Gunreet has made 'great progress' since her treatment. 'When Gunreet was about seven months old I noticed she wasn't reaching her milestones at the same age that her older brother did,' she said. 'She couldn't hold her own head up or reach out for items. She cried a lot and always wanted to be held. 'Since having the gene therapy, Gunreet has made great progress. 'She cries less, smiles more, and can reach for objects. 'She can hold her head up and is trying to sit up, she's recently learned how to roll from her stomach to her back which is fantastic to see. 'It means a lot to me that Gunreet was able to have this gene therapy – her general health has improved, she has more co-ordination, she can bring her palms together and is able to move her hand to her mouth.' AADC deficiency is caused by a mutation in the gene that produces the AADC enzyme, this enzyme is needed to produce a neurotransmitter called dopamine which is important in controlling movement. People with AADC deficiency do not have a working version of the enzyme, which means that they have little or no dopamine in the brain. This means that they can suffer developmental delays, weak muscle tone and inability to control the movement of the limbs. It can also lead to painful episodes for affected children. The condition is rare and often deadly, with many children with AADC deficiency not reaching adulthood. The medicine, also known as eladocagene exuparvovec, consists of a virus that contains a working version of the AADC gene. The treatment is delivered by millimetre precision to an exact location in the brain of the patient by a team of medics assisted by a robotic surgery tool. When given to the patient, it is expected that the virus will carry the AADC gene into nerve cells, enabling them to produce the missing enzyme. This is expected to enable the cells to produce the dopamine they need to work properly, which will improve symptoms of the condition. It is the first NHS England commissioned gene therapy in the UK infused directly into the brain. Professor Manju Kurian, consultant paediatric neurologist at GOSH, said 'AADC deficiency is a rare condition but often a cruel one that has such a profound impact on children and their carers and families. 'We know children with the condition have painful episodes that can last for hours and, as their condition progresses, their life becomes more and more difficult. 'It's incredible to me that I can now prescribe novel gene therapies just as I would prescribe paracetamol and antibiotics. 'While the treatment is now available under the NHS at GOSH, we can only do this by working collaboratively across teams inside and outside the hospital, from physios and surgeons to dietitians and speech therapists, alongside partnerships with companies who supply these therapies. 'It's great to see how this treatment has been able to help babies and children across the country like Gunreet. 'The natural history of the condition is that most patients cannot fully hold their head or make any developmental progress after that milestone. 'Gunreet's progress over the last year has been really impressive in that context, as well as the virtual disappearance of the eye crises. 'We're hopeful that one day she will be able to talk or walk, as seen in some of the young patients treated in the clinical trial.' Professor James Palmer, NHS medical director for specialised commissioning, said: 'This is wonderful news for Gunreet and her family, and a powerful example of how these commitments are translating into real improvements in people's lives. 'By bringing cutting-edge medicines like eladocagene exuparvovec into the health service and setting up our expert clinical teams to successfully deliver them, the NHS is making clear its commitment to improving care through innovation.'
BBC News
2 hours ago
- BBC News
Ovarian cancer: Widower warns of 'sneaky' symptoms
A widower has said his wife received a late and terminal diagnosis due to an ongoing lack of awareness about symptoms of ovarian cancer among health McCormick, whose wife Julie was diagnosed with stage 3 ovarian cancer, said the disease shouldn't be ruled out as symptoms can be associated with other less serious 200 women are diagnosed with ovarian cancer in Northern Ireland each year. The Department of Health and the Public Health Agency both said that due to constraints on the health budget there has been a "freeze" on almost all advertising spend across Health and Social Care. "I think doctors need to rule it in before they rule it out, particularly if symptoms persist when a woman is being investigated for gynaecological or stomach problems," the County Down man first complained of pelvic pain in 2021, however, it took a further two and a half years of investigations and tests before ovarian cancer was diagnosed. Julie died 12 months later, aged McCormick said his wife, an oncology nurse, was "fooled" by early tests being negative despite prolonged symptoms telling her something wasn't right.A CA125 blood test, which is used to measure a level of protein in the blood and is not a definitive test for ovarian cancer was initially clear and caused no according to Mr McCormick, despite his wife's constant visits to the GP and other specialists with stomach pain and gynae issues, ovarian cancer wasn't a line of inquiry. 'On a mission' Mr McCormick said he's "passionate" about raising awareness of ovarian cancer and is "on a mission" to get a public awareness campaign up and running across Northern mission began on 23 June 2024, the day Julie died. Posting on social media that day, Mr McCormick urged the public to be aware of the "sneaky symptoms" of ovarian cancer and to get checked if they persist. One year on, he said little has changed with no desire among politicians and health officials to put it on the Executive's agenda."I'd like a big billboard, radio and television campaign educating people about the symptoms and that if they persist you should continue seeking help and suggesting being tested for ovarian cancer," said Mr McCormick. "When you are diagnosed late, the outcomes are much poorer and therefore if women can get to see their GP sooner, they have a better chance of being diagnosed and a better chance of survival."He also said he isn't confident that the Department of Health will decide to go big on the cancer as he appreciates it has a long list of priorities. Research by Queen's University Belfast has found the most common route for women to be diagnosed with ovarian cancer was in an Emergency 2017 and 2021, 35% (70) of cases were diagnosed on average each year via an emergency presentation, and 27% (55) of cases were diagnosed by a red-flag referral Damien Bennett, director of the NI Cancer Registry, said the findings highlighted the need to drive home the message that if symptoms persist - including if they happen 12 times in a month - it is not something that should be ignored and should be immediately followed up with the woman's GP."These symptoms can overlap with other conditions that are benign and can potentially make it more difficult for the public to potentially approach health care professionals," he said. "Those symptoms also make it more difficult for health care professionals to come to a diagnosis - but the greater awareness about all of this the better."The research also found that 32% of cases were diagnosed at stage 1 (early stage), while 20% were diagnosed at an advanced average there were 122 deaths per year from ovarian cancer.
